Shanghai MicroPort MedBot (Group) Co (HKSE:02252) Altman Z-Score: 11.68 (As of Aug. 14, 2026) — Near Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02252 Shanghai MicroPort MedBot (Group) Co Ltd HKSE:02252
45 GF Score
Price HK$25.48
GF Value HK$81.81
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Shanghai MicroPort MedBot (Group) Co Altman Z-Score?

Shanghai MicroPort MedBot (Group) Co HKSE:02252 -1.32% 45 Altman Z-Score is 11.68 as of Aug. 14, 2026, which is 7% above its 10-year median of 10.93. GuruFocus rates HKSE:02252 with a GF Score™ of 45/100 and a GF Value™ of HK$81.81 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 808 Medical Devices & Instruments companies, Shanghai MicroPort MedBot (Group) Co ranks better than 86.01% on this metric.

The Altman Z-Score is a model designed to predict the likelihood of a company going bankrupt within the next two years. Created by American finance professor Edward Altman in 1968, the model is specifically designed for publicly traded manufacturing companies with assets greater than $1 million.

Good Sign:

Altman Z-score of 11.68 is strong.

Shanghai MicroPort MedBot (Group) Co has a Altman Z-Score of 11.68, indicating it is in Safe Zones. This implies the Altman Z-Score is strong.

The zones of discrimination were as such:

When Altman Z-Score <= 1.8, it is in Distress Zones.
When Altman Z-Score >= 3, it is in Safe Zones.
When Altman Z-Score is between 1.8 and 3, it is in Grey Zones.

The historical rank and industry rank for Shanghai MicroPort MedBot (Group) Co's Altman Z-Score or its related term are showing as below:

HKSE:02252' s Altman Z-Score Range Over the Past 10 Years
Min: 0.34   Med: 10.93   Max: 68.57
Current: 11.68

During the past 7 years, Shanghai MicroPort MedBot (Group) Co's highest Altman Z-Score was 68.57. The lowest was 0.34. And the median was 10.93.


Shanghai MicroPort MedBot (Group) Co  (HKSE:02252) Altman Z-Score Explanation

X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.

X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.

X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.

X4, Market Value of Equity/Book Value of Total Liabilities (MVE/TL): The measure shows how much the firm's assets can decline in value (measured by market value of equity plus debt) before the liabilities exceed the assets and the firm becomes insolvent.

X5, Revenue/Total Assets (S/TA): The capital-turnover ratio is a standard financial ratio illustrating the sales generating ability of the firm's assets.

Read more about Altman Z-Score and the original research.


Be Aware

Altman Z-Score does not apply to financial companies.


Shanghai MicroPort MedBot (Group) Co Altman Z-Score Related Terms


Shanghai MicroPort MedBot (Group) Co Altman Z-Score Historical Data

* Premium members only.

The historical data trend for Shanghai MicroPort MedBot (Group) Co's Altman Z-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai MicroPort MedBot (Group) Co Altman Z-Score Chart

Shanghai MicroPort MedBot (Group) Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Altman Z-Score
Get a 7-Day Free Trial 68.57 29.91 6.87 0.34 10.93

Shanghai MicroPort MedBot (Group) Co Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Altman Z-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.87 0.00 0.34 0.00 10.93

HKSE:02252 vs ABT, SYK, MDT: Altman Z-Score Comparison

For the Medical Devices subindustry, Shanghai MicroPort MedBot (Group) Co's Altman Z-Score, along with its competitors' market caps and Altman Z-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai MicroPort MedBot (Group) Co Altman Z-Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Shanghai MicroPort MedBot (Group) Co's Altman Z-Score distribution charts can be found below:

* The bar in red indicates where Shanghai MicroPort MedBot (Group) Co's Altman Z-Score falls into.


HKSE:02252
45GF Score
Shanghai MicroPort MedBot (Group) Co Ltd HKSE:02252
Altman Z-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shanghai MicroPort MedBot (Group) Co Altman Z-Score Calculation

Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

Shanghai MicroPort MedBot (Group) Co's Altman Z-Score for today is calculated with this formula:

Z=1.2*X1+1.4*X2+3.3*X3+0.6*X4+1.0*X5
=1.2*0.4386+1.4*-2.8189+3.3*-0.1757+0.6*25.4499+1.0*0.4129
=11.68

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z-Score when X4 or X5 value is 0.

Trailing Twelve Months (TTM) ended in Dec. 2025:
Total Assets was HK$1,474.4 Mil.
Total Current Assets was HK$1,144.1 Mil.
Total Current Liabilities was HK$497.3 Mil.
Retained Earnings was HK$-4,156.0 Mil.
Pre-Tax Income was HK$-280.7 Mil.
Interest Expense was HK$-21.7 Mil.
Revenue was HK$608.8 Mil.
Market Cap (Today) was HK$26,278.3 Mil.
Total Liabilities was HK$1,032.6 Mil.

* Note that for stock reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data.

X1=Working Capital/Total Assets
=(Total Current Assets - Total Current Liabilities)/Total Assets
=(1144.052 - 497.335)/1474.358
=0.4386

X2=Retained Earnings/Total Assets
=-4156.015/1474.358
=-2.8189

X3=Earnings Before Interest and Taxes/Total Assets
=(Pre-Tax Income - Interest Expense)/Total Assets
=(-280.727 - -21.729)/1474.358
=-0.1757

X4=Market Value Equity/Book Value of Total Liabilities
=Market Cap/Total Liabilities
=26278.297/1032.551
=25.4499

X5=Revenue/Total Assets
=608.78/1474.358
=0.4129

The zones of discrimination were as such:

Distress Zones - 1.81 < Grey Zones < 2.99 - Safe Zones

Shanghai MicroPort MedBot (Group) Co has a Altman Z-Score of 11.68 indicating it is in Safe Zones.

Study by Altman found that companies that are in Distress Zone have more than 80% of chances of bankruptcy in two years.

Frequently Asked Questions Learn more about Altman Z-Score →
What does a Altman Z-Score of 11.68 mean?
Shanghai MicroPort MedBot (Group) Co (HKSE:02252) has a Altman Z-Score of 11.68 as of Aug. 14, 2026. The Altman Z-score measures a company's bankruptcy risk. View historical data on Shanghai MicroPort MedBot (Group) Co and its competitors. This is near median its historical median of 10.93. Over the past decade, Shanghai MicroPort MedBot (Group) Co's Altman Z-Score has ranged from 0.34 to 68.57. According to the industry distribution chart, Shanghai MicroPort MedBot (Group) Co ranks #113 out of 808 companies in the Medical Devices & Instruments industry, placing it in the top 14%.
Is Shanghai MicroPort MedBot (Group) Co's Altman Z-Score too high?
Shanghai MicroPort MedBot (Group) Co's current Altman Z-Score of 11.68 is near median its 10-year median of 10.93. Over the past 10 years, this metric has ranged from a low of 0.34 to a high of 68.57. The Medical Devices & Instruments industry median Altman Z-Score is 3.06. Shanghai MicroPort MedBot (Group) Co's value of 11.68 is 282.3% above this industry median. Based on the distribution chart, Shanghai MicroPort MedBot (Group) Co ranks #113 out of 808 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Shanghai MicroPort MedBot (Group) Co has a GF Score™ of 45/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Shanghai MicroPort MedBot (Group) Co's Altman Z-Score compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Shanghai MicroPort MedBot (Group) Co ranks #113 out of 808 companies for Altman Z-Score. This places Shanghai MicroPort MedBot (Group) Co in the top 14% of its industry — outperforming the majority of peers. The industry median Altman Z-Score is 3.06. Shanghai MicroPort MedBot (Group) Co's value of 11.68 is 282.3% above this benchmark. Historically, Shanghai MicroPort MedBot (Group) Co's own Altman Z-Score has ranged from 0.34 to 68.57 over the past decade. While the company's 10-year median is 10.93 vs. the industry median of 3.06, Shanghai MicroPort MedBot (Group) Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Altman Z-Score for a Medical Devices & Instruments company?
The median Altman Z-Score among Medical Devices & Instruments companies is 3.06, based on 808 companies in the industry. Companies in the top quartile (top 25%) have a Altman Z-Score significantly above this median, while those in the bottom quartile fall well below. However, Altman Z-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shanghai MicroPort MedBot (Group) Co's current Altman Z-Score of 11.68 is 282.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Altman Z-Score mean?
A high Altman Z-Score can signal that a stock is expensive relative to its fundamentals. The Altman Z-score measures a company's bankruptcy risk. View historical data on Shanghai MicroPort MedBot (Group) Co and its competitors. For the Medical Devices & Instruments industry, the median Altman Z-Score is 3.06 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shanghai MicroPort MedBot (Group) Co's current Altman Z-Score is 11.68, which is near median its own 10-year median of 10.93. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai MicroPort MedBot (Group) Co stock overvalued right now?
Based on GuruFocus' analysis, Shanghai MicroPort MedBot (Group) Co (HKSE:02252) is currently considered Possible Value Trap. The stock's GF Value™ is HK$81.81, compared to a current price of HK$25.48 — trading 68.9% below its estimated fair value. The current Altman Z-Score is 11.68, which is near median its 10-year median of 10.93 and 282.3% above the Medical Devices & Instruments industry median of 3.06. Shanghai MicroPort MedBot (Group) Co's overall GF Score™ is 45/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Altman Z-Score calculated?
Altman Z-Score is calculated from a company's financial statements. For Shanghai MicroPort MedBot (Group) Co (HKSE:02252), the current Altman Z-Score is 11.68 as of Aug. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shanghai MicroPort MedBot (Group) Co (HKSE:02252) Overvalued in 2026?

Based on GuruFocus' analysis, Shanghai MicroPort MedBot (Group) Co stock appears to be undervalued. The current stock price of HK$25.48 is trading 68.9% below its estimated GF Value™ of HK$81.81. GuruFocus considers Shanghai MicroPort MedBot (Group) Co to be Possible Value Trap.

Key valuation signals for HKSE:02252:

  • Altman Z-Score: 11.68 (near median its 10-year median of 10.93)
  • GF Value™: HK$81.81 vs. price of HK$25.48 (68.9% below fair value)
  • GF Score™: 45/100 with 3 warning signs
  • Industry Position: 282.3% above the Medical Devices & Instruments median (#113 of 808)

No single metric tells the full story. See the HKSE:02252 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Shanghai MicroPort MedBot (Group) Co Business Description

Address 1601 Zhangdong Road, Room 101, Area B, Building 1, China (Shanghai) Pilot Free Trade Zone, Shanghai, CHN
Shanghai MicroPort MedBot (Group) Co Ltd is a surgical robot company dedicated to designing, developing, and commercializing surgical robots to assist surgeons in performing complex surgical procedures. The business of the company covers various surgical specialties of laparoscopic, orthopedic, panvascular, natural orifice, and percutaneous surgical procedures, and has accumulated several products at various stages as those in development, clinical trials, registration, and commercialisation. The company derives revenue principally from the sales of surgical robot systems, instruments, and accessories, and the provision of services through appointed distributors. Geographically, it derives maximum revenue from the People's Republic of China.
45GF Score

Get the complete analysis for HKSE:02252

Altman Z-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$25.48
Price
HK$81.81
GF Value